Drugstore chain CVS Health Corporation (NYSE: CVS) is no longer offering Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine in many of its retail locations, the company told CNBC on Wednesday.
According to CVS spokesman Mike DeAngelis, retail locations continue to offer either the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) vaccine.
DeAngelis said the change was implemented "several weeks ago and helps us manage our vaccine supply across the chain, both in our pharmacies and clinics."
He added that the Johnson & Johnson vaccine is still offered at almost 1,000 of its MinuteClinic locations in 25 states and Washington, D.C.
The Johnson & Johnson vaccine was touted as a potential game-changer when it was initially authorized, being a single-dose shot, and can be stored at normal refrigerator temperatures.
But the vaccine has been beset by production issues and concerns about its effectiveness against the delta variant.
Price Action: CVS shares are down 2.4% at $79.63 during the market session on the last check Thursday.
Photo by Johaehn from Pixabay
See more from Benzinga
Click here for options trades from Benzinga
Moderna COVID-19 Shot Is 93% Effective After Six Months Of Second Dose
UK Competition And Markets Authority Accuses Pfizer Of Illegal Pricing Of Its Epilepsy Drug
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
